Read + Share
Amedeo Smart
Independent Medical Education
Tung NM, Li T, Garber JE. Reply to: Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy. J Clin Oncol 2026 Jul 7:JCO2600940. doi: 10.1200/JCO-26-00940.PMID: 42413078
Email
LinkedIn
Privacy Policy